Key result
Percutaneous left atrial appendage occlusion in patients with atrial fibrillation and previous intracranial hemorrhage resulted in no procedure-related complications or strokes over 13.6 months.
Why the study?
Is percutaneous LAAO safe and feasible in patients with atrial fibrillation and previous intracranial hemorrhage?
Observational (n=20)
No
Is percutaneous LAAO safe and feasible in patients with atrial fibrillation and previous intracranial hemorrhage?
Percutaneous LAAO appears safe and feasible for stroke prevention in high-risk patients with atrial fibrillation and a history of intracranial hemorrhage.
No takes yet. Share an insight, caveat, or question.
Supports LAAO feasibility in high-risk AF with prior ICH; leaves open need for randomized trials before practice change.
Horstmann et al. (2013) conducted an observational in Atrial fibrillation and previous intracranial hemorrhage (n=20). Percutaneous left atrial appendage occlusion (LAAO) was evaluated on Major complications (periprocedural stroke, death, pericardial effusion, device embolism) and ischemic or hemorrhagic stroke. Percutaneous left atrial appendage occlusion in patients with atrial fibrillation and previous intracranial hemorrhage resulted in no procedure-related complications or strokes over 13.6 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: